SEC Filing Summary: Form 13F Information Table
Business Context and Reporting Period
This filing is a Form 13F Information Table submitted to the U.S. Securities and Exchange Commission. The reporting period covers holdings as of September 30, 2022. The filer is identified in the metadata as Palantir Technologies Inc., though the document lists holdings in various other issuers, indicating Palantir is the reporting investment manager disclosing its portfolio positions.
Key Financial Metrics and Portfolio Composition
The filing details a portfolio of 21 equity positions. The table provides the value of each holding (in thousands of USD) and the number of shares held. The filing does not contain data on Palantir's own revenue, profit, cash flow, or debt, as Form 13F reports only the securities held by the investment manager.
| Issuer Name | Value ($000s) | Shares Held | Voting Authority |
|---|---|---|---|
| Rubicon Technologies, Inc. | 7,455 | 3,500,000 | Sole |
| Roivant Sciences Ltd. | 7,247 | 2,250,563 | Sole |
| Tritium DCFC Limited | 7,178 | 2,250,000 | Sole |
| Allego N.V. | 7,074 | 1,622,416 | Sole |
| AdTheorent Holding Company, Inc. | 2,586 | 1,202,836 | Sole |
| Sarcos Technology and Robotics Corporation | 2,688 | 1,211,003 | Sole |
| Starry Group Holdings, Inc. | 2,502 | 1,679,445 | Sole |
| Boxed, Inc. | 1,844 | 2,000,000 | Sole |
| Rigetti Computing, Inc. | 1,880 | 1,000,000 | Sole |
| Faraday Future Intelligent Electric Inc. | 1,272 | 2,000,000 | Sole |
| Babylon Holdings Limited | 1,351 | 2,862,373 | Sole |
| Energy Vault Holdings, Inc. | 3,142 | 595,000 | Sole |
| Fast Radius, Inc. | 768 | 1,910,506 | Sole |
| Wejo Group Limited | 3,815 | 3,500,000 | Sole |
| Pear Therapeutics, Inc. | 2,040 | 1,000,000 | Sole |
| MSP Recovery, Inc. | 772 | 643,663 | Sole |
| Lilium N.V. | 935 | 410,000 | Sole |
| Bird Global, Inc. | 706 | 2,000,000 | Sole |
| BlackSky Technology Inc. | 120 | 80,000 | Sole |
| Celularity Inc. | 274 | 118,727 | Sole |
Note: The filing lists "Sole" voting authority for all positions. No put or call options are reported.
Material Changes and Comparisons
The filing text does not provide data for a prior comparable period. Consequently, material changes in holdings, value, or share counts versus previous quarters cannot be determined from this document alone.
Guidance, Outlook, and Risks
This Form 13F is a statutory disclosure of holdings and does not contain management commentary, financial guidance, outlook, or specific risk factors regarding the issuers or the filer's strategy. The document includes a standard disclaimer that the SEC has not reviewed the information for accuracy or completeness.
Key Facts for Investor Verification
- Portfolio Concentration: The top three holdings by value are Rubicon Technologies ($7.455M), Roivant Sciences ($7.247M), and Tritium DCFC ($7.178M).
- Investment Style: The portfolio consists entirely of common stock or ordinary shares in growth-oriented technology, biotech, and energy companies, with no derivatives reported.
- Reporting Entity: Verify that Palantir Technologies Inc. is the correct reporting manager, as the portfolio does not include Palantir's own stock.
- Data Limitations: This document provides a snapshot of holdings at a single point in time (Sep 30, 2022) and does not reflect subsequent trading activity or current market values.